Evidence map›Paper›PMID 31410016›Full record

ArticleOncoTargets and therapy2019

miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.

Huiying Fang, Wei Jiang, Zhouhong Jing, Xiaosong Mu, Zhongxun Xiong

Abstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huiying FangDepartment of Breast Disease, Chongqing University Cancer Hospital, Chongqing City, 400000, People's Republic of China.
Wei JiangDepartment of Breast Disease, Chongqing University Cancer Hospital, Chongqing City, 400000, People's Republic of China.
Zhouhong JingDepartment of Breast Disease, Chongqing University Cancer Hospital, Chongqing City, 400000, People's Republic of China.
Xiaosong MuDepartment of Breast Disease, Chongqing University Cancer Hospital, Chongqing City, 400000, People's Republic of China.
Zhongxun XiongDepartment of Breast Disease, Chongqing University Cancer Hospital, Chongqing City, 400000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

APAF1apoptosisbreast cancercell proliferationmiR-937

Identifiers

PMID31410016
PMCPMC6645689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.